Factorial Designs with Time-to-Event Endpoints

[1]  J. Crowley,et al.  Evaluation of cisplatin intensity in metastatic non-small-cell lung cancer: a phase III study of the Southwest Oncology Group. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  Ping-Yu Liu,et al.  Factorial design considerations. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  R. Simon,et al.  Extension of one-sided test to multiple treatment trials. , 1994, Controlled clinical trials.

[4]  Alan A Montgomery,et al.  Bmc Medical Research Methodology Open Access Design, Analysis and Presentation of Factorial Randomised Controlled Trials , 2022 .

[5]  S. Dahlberg,et al.  Design and analysis of multiarm clinical trials with survival endpoints. , 1995, Controlled clinical trials.

[6]  M. Tsubokura,et al.  Weekly paclitaxel in the adjuvant treatment of breast cancer. , 2008, The New England journal of medicine.

[7]  O. J. Dunn,et al.  Estimation of Multiple Contrasts Using T-distributions , 1965 .

[8]  H M Hung.  Two-stage tests for studying monotherapy and combination therapy in two-by-two factorial trials. , 1993, Statistics in medicine.

[9]  M. Gail,et al.  Factorial trial of three interventions to reduce the progression of precancerous gastric lesions in Shandong, China: design issues and initial data. , 1998, Controlled clinical trials.

[10]  D P Byar.  Factorial and reciprocal control designs. , 1990, Statistics in medicine.

[11]  E V Slud.  Analysis of factorial survival experiments. , 1994, Biometrics.

[12]  F. Cognetti,et al.  Factorial design for randomized clinical trials. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[13]  W. Tsai,et al.  Design and analysis for survival data under order restrictions with a modified logrank test. , 1998, Statistics in medicine.

[14]  K. Gabriel,et al.  On closed testing procedures with special reference to ordered analysis of variance , 1976 .

[15]  Douglas G Altman,et al.  Analysis and reporting of factorial trials: a systematic review. , 2003, JAMA.

[16]  H M Hung.  Evaluation of a combination drug with multiple doses in unbalanced factorial design clinical trials. , 2000, Statistics in medicine.

[17]  E. Perez,et al.  Weekly paclitaxel in the adjuvant treatment of breast cancer. , 2008, The New England journal of medicine.

[18]  Stephen L. George,et al.  Sample size requirements and length of study for testing interaction in a 1 × k factorial design when time-to-failure is the outcome , 1993 .

[19]  R Simon,et al.  Bayesian design and analysis of two x two factorial clinical trials. , 1997, Biometrics.